Pharmaceuticals

Pharmaceuticals Drug Development Pharmaceuticals Market Competition Drug Development Treatment Options Drug Manufacturing Drug Pricing Tariffs Medications

3 ARTICLES

16h ago

Molecule Targeting Chlamydia Identified, Paving Way for Precision Antibiotics

Researchers from Umeå University and Michigan State University discover a molecule that inhibits Chlamydia trachomatis growth without harming beneficial bacteria, advancing targeted antimicrobial development.

Stories older than 24h

14 ARTICLES

yesterday

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

3 ARTICLES

2d ago

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

18 ARTICLES

last wk.

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

10 ARTICLES

last wk.

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

6 ARTICLES

last wk.

Janelle Rohner Issues Refunds After GLP-1 Weight Loss Disclosure

6 ARTICLES

last wk.

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

5 ARTICLES

last wk.

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

9 ARTICLES

2w ago

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

5 ARTICLES

2w ago

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

3 ARTICLES

2w ago

Senolytic Drugs Clear 'Zombie Cells,' Offer New Hope for Chronic Back Pain Treatment

7 ARTICLES

2w ago

California Expands Access to Affordable Naloxone for Residents

3 ARTICLES

2w ago

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

4 ARTICLES

2w ago

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

3 ARTICLES

3w ago

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

12 ARTICLES

3w ago

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

7 ARTICLES

4w ago

Study Reveals Pharmaceutical Pollution Alters Salmon Migration and Behavior

Particle.news

Pharmaceuticals

Molecule Targeting Chlamydia Identified, Paving Way for Precision Antibiotics

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

HHS Secretary Kennedy's Vaccine Policies Deepen Measles Crisis

‘Ozempic Mouth’ Identified as New Cosmetic Concern for Weight-Loss Drug Users

Psilocybin Pilot Study Shows Weeks-Long Symptom Relief in Parkinson’s Patients

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Janelle Rohner Issues Refunds After GLP-1 Weight Loss Disclosure

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Never miss stories about

Pharmaceuticals

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Senolytic Drugs Clear 'Zombie Cells,' Offer New Hope for Chronic Back Pain Treatment

California Expands Access to Affordable Naloxone for Residents

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Study Reveals Pharmaceutical Pollution Alters Salmon Migration and Behavior

Never miss stories about

Pharmaceuticals